U.S. Global Investors (USGI)’s Core Laboratories CLB Stock Holding History

U.S. Global Investors (USGI)’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-8,800	Closed	-$957K	–	200
2015 Q4	$957K	Buy	8,800 +6,800	+340%	+$778K	0.5%	76
2015 Q3	$200K	Buy	+2,000	New	+$218K	0.11%	159
2014 Q1	–	Sell	-3,000	Closed	-$573K	–	319
2013 Q4	$573K	Sell	3,000 -1,000	-25%	-$186K	0.1%	164
2013 Q3	$677K	Hold	4,000	–	–	0.12%	146
2013 Q2	$607K	Buy	+4,000	New	+$567K	0.1%	151

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

U.S. Global Investors (USGI)'s CLB Position: Q1 2016 in Review

U.S. Global Investors (USGI) sold out of Core Laboratories (CLB) in Q1 2016, closing a stake of 8,800 shares — an estimated $957K sold.

U.S. Global Investors (USGI) first reported a position in CLB in Q2 2013 and held it in 5 quarters. The position peaked at $957K in Q4 2015. 365 funds tracked by Wall St. Rank hold CLB as of Q1 2016.

U.S. Global Investors (USGI) reported no remaining Core Laboratories position as of Q1 2016 after selling out during the quarter.
U.S. Global Investors (USGI) sold 8,800 Core Laboratories shares in Q1 2016, an estimated $957K.
U.S. Global Investors (USGI) first reported a position in Core Laboratories in Q2 2013 and held it in 5 quarters.
U.S. Global Investors (USGI)'s Core Laboratories position peaked at $957K in Q4 2015.
365 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2016.

Based on U.S. Global Investors (USGI)'s 13F filing for Q1 2016, filed 13 May 2016.